Stanton Optical | |
12413 E 96th St N, Owasso, OK 74055-5317 | |
(877) 350-3399 | |
Not Available |
Full Name | Stanton Optical |
---|---|
Type | Facility |
Speciality | Eyewear Supplier |
Location | 12413 E 96th St N, Owasso, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952068074 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Secondary |
332H00000X | Eyewear Supplier | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stanton Optical 1615 S Congress Ave Ste 105, Delray Beach, FL 33445-6326 Ph: (561) 208-8464 | Stanton Optical 12413 E 96th St N, Owasso, OK 74055-5317 Ph: (877) 350-3399 |
News Archive
People who work in health care are failing to give patients crucial information about the link between obesity and cancer according to new research presented today at the National Cancer Research Institute Cancer Conference (NCRI) in Liverpool.
A robotic wheelchair is being developed that will help children learn to 'drive'. Researchers writing in BioMed Central's open access Journal of NeuroEngineering and Rehabilitation describe the testing of ROLY -RObot-assisted Learning for Young drivers - in a group of children without disabilities and one child with cerebral palsy.
Two-thirds of transgender teens have depression, and many also have suicidal thoughts and self-injuring behavior, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Esperance Pharmaceuticals today announced that it has begun enrollment of a Phase 2, randomized, multi-center trial of EP-100 in combination with paclitaxel for the potential treatment of advanced ovarian cancer.
The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer, has awarded additional funding of up to $16 million to four teams of top researchers as part of its "New Therapies Challenge Grants," the American Association for Cancer Research, Scientific Partner of SU2C, announced today.
› Verified 8 days ago